Statins Versus Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors- Are We Doing Better? A Systematic Review on Treatment Disparity

Coronary artery disease (CAD) is a significant contributor to mortality in America. A common risk factor of CAD is hyperlipidemia. Treatment guidelines of hyperlipidemia are well established. Statins are the cornerstone of treating hyperlipidemia. New medications such as proprotein convertase subtil...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Chetana, Valero, Danel J, Nisar, Javariya, Trujillo Ramirez, Jose I, Kothari, Karisma K, Isola, Sasank, San Hernandez, Aleyda M, Gordon, Domonick K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667606/
https://www.ncbi.nlm.nih.gov/pubmed/33209524
http://dx.doi.org/10.7759/cureus.10965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667606/
https://www.ncbi.nlm.nih.gov/pubmed/33209524
http://dx.doi.org/10.7759/cureus.10965

Ejemplares similares